Terms: = Testicular cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
48 results:
1. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Carus A; Rosenvilde JJ; Berney D; Daugaard G
Eur J Cancer; 2024 May; 202():114025. PubMed ID: 38531266
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Factors for Relapse in Patients With clinical Stage I testicular Seminoma: A Nationwide, Population-Based Cohort Study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Rosenvilde JJ; Berney D; Daugaard G
J Clin Oncol; 2024 Jan; 42(1):81-89. PubMed ID: 37683134
[TBL] [Abstract] [Full Text] [Related]
3. Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.
Zhang H; Jiang D; Meng E; Zhao M; Niu B
Immunotherapy; 2023 Jan; 15(1):17-25. PubMed ID: 36647794
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor.
Blok JM; van der Poel HG; Kerst JM; Bex A; Brouwer OR; Bosch JLHR; Horenblas S; Meijer RP
World J Urol; 2021 Jun; 39(6):1969-1976. PubMed ID: 32955662
[TBL] [Abstract] [Full Text] [Related]
5. clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review.
Haarsma R; Blok JM; van Putten K; Meijer RP
Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
[TBL] [Abstract] [Full Text] [Related]
7. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
[TBL] [Abstract] [Full Text] [Related]
8. Gonadal function in adult male patients with congenital adrenal hyperplasia.
Engels M; Gehrmann K; Falhammar H; Webb EA; Nordenström A; Sweep FC; Span PN; van Herwaarden AE; Rohayem J; Richter-Unruh A; Bouvattier C; Köhler B; Kortmann BB; Arlt W; Roeleveld N; Reisch N; Stikkelbroeck NMML; Claahsen-van der Grinten HL;
Eur J Endocrinol; 2018 Mar; 178(3):285-294. PubMed ID: 29339528
[TBL] [Abstract] [Full Text] [Related]
9. testicular seminoma: Are clinical features and treatment outcomes any different in India?
Anjanappa M; Kumar A; Mathews S; Joseph J; Jagathnathkrishna KM; James FV
Indian J Cancer; 2017; 54(1):385-387. PubMed ID: 29199728
[TBL] [Abstract] [Full Text] [Related]
10. IVF outcome in azoospermic cancer survivors.
Dar S; Orvieto R; Levron J; Haas J; Gat I; Raviv G
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():84-87. PubMed ID: 29179011
[TBL] [Abstract] [Full Text] [Related]
11. [clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
12. Evaluation of the decision-making process in the conservative approach to small testicular masses.
Benelli A; Varca V; Derchi L; Gregori A; Carmignani G; Simonato A
Urologia; 2017 Apr; 84(2):83-87. PubMed ID: 28315499
[TBL] [Abstract] [Full Text] [Related]
13. Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in testicular Germ-Cell Tumor Patients.
Svetlovska D; Miskovska V; Cholujova D; Gronesova P; Cingelova S; Chovanec M; Sycova-Mila Z; Obertova J; Palacka P; Rajec J; Kalavska K; Usakova V; Luha J; Ondrus D; Spanik S; Mardiak J; Mego M
Clin Genitourin Cancer; 2017 Jun; 15(3):411-416.e2. PubMed ID: 28237180
[TBL] [Abstract] [Full Text] [Related]
14. Differences in global DNA methylation of testicular seminoma are not associated with changes in histone modifications, clinical prognosis, BRAF mutations or gene expression.
Pedersen LH; Nielsen JE; Daugaard G; Hansen TV; Rajpert-De Meyts E; Almstrup K
Cancer Genet; 2016 Nov; 209(11):506-514. PubMed ID: 27886677
[TBL] [Abstract] [Full Text] [Related]
15. Pelvic Lymph Node Dissection in Patients Treated for Testis cancer: The Memorial Sloan Kettering cancer Center Experience.
Alanee SR; Carver BS; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2016 Sep; 95():128-31. PubMed ID: 27235751
[TBL] [Abstract] [Full Text] [Related]
16. Ullrich-Turner Syndrome and Tumor Risk: Is There Another Chance to Early Gonadectomy in Positive TSPY and SRY Patients?
Silveri M; Grossi A; Bassani F; Orazi C; Camassei FD; Zaccara A
Eur J Pediatr Surg; 2016 Jun; 26(3):273-6. PubMed ID: 25978024
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcome, Hormonal Status, Gonadotrope Axis, and testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey.
Bouvattier C; Esterle L; Renoult-Pierre P; de la Perrière AB; Illouz F; Kerlan V; Pascal-Vigneron V; Drui D; Christin-Maitre S; Galland F; Brue T; Reznik Y; Schillo F; Pinsard D; Piguel X; Chabrier G; Decoudier B; Emy P; Tauveron I; Raffin-Sanson ML; Bertherat J; Kuhn JM; Caron P; Cartigny M; Chabre O; Dewailly D; Morel Y; Touraine P; Tardy-Guidollet V; Young J
J Clin Endocrinol Metab; 2015 Jun; 100(6):2303-13. PubMed ID: 25822101
[TBL] [Abstract] [Full Text] [Related]
18. clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
[TBL] [Abstract] [Full Text] [Related]
19. Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer.
Sapre N; Pedersen J; Hong MK; Harewood L; Peters J; Costello AJ; Hovens CM; Corcoran NM
BJU Int; 2012 Dec; 110 Suppl 4():58-63. PubMed ID: 23194127
[TBL] [Abstract] [Full Text] [Related]
20. Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view.
Huber J; Herpel E; Jakobi H; Hadaschik BA; Pahernik S; Hohenfellner M
Urol Oncol; 2013 Oct; 31(7):990-6. PubMed ID: 22386623
[TBL] [Abstract] [Full Text] [Related]
[Next]
